Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants

Abstract excerpt

The novel SARS-CoV-2 variants of concern (VOC) represent a considerable global alarm because their mutations are known to affect transmissibility and cause immune escape. While preventing severe disease and deaths, the available vaccines do not avoid infection; therefore, COVID-19 disease management still requires effective therapies. We have recently reported that the aminothiol cysteamine, a drug already...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19 Clinical Research Studies
• Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
• Share to Retinal and Optic Conditions